GE HealthCare Technologies Quarterly Cash Flow Statement
NASDAQ: GEHCHealth CareMedical ElectronicsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GE HealthCare Technologies free cash flow
In the quarter ended Mar 31, 2026, GE HealthCare Technologies generated $290.0 million of operating cash flow and spent $178.0 million on capital expenditures. That left free cash flow of $112.0 million, a free-cash-flow margin of 2.2% of revenue. Free cash flow was up 14.3% from the prior year's $98.0 million.
GE HealthCare Technologies returned $116.0 million to shareholders: $16.0 million in dividends and $100.0 million in share repurchases, equal to 104% of free cash flow. Free cash flow covered dividend payments 7.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
GE HealthCare Technologies cash flow statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 411.00M | 602.00M | 464.00M | 500.00M | 588.00M | 738.00M | 490.00M | 435.00M | 388.00M | 416.00M | 382.00M | 433.00M |
| Net Income growth (YoY) | -30.10% | -18.43% | -5.31% | +14.94% | +51.55% | +77.40% | +28.27% | +0.46% | +1.31% | -27.40% | -22.52% | -13.05% |
| Depreciation & Amortization | 78.00M | 74.00M | 75.00M | 72.00M | 66.00M | 65.00M | 66.00M | 69.00M | 68.00M | 60.00M | 64.00M | 63.00M |
| Stock-Based Compensation | 35.00M | 36.00M | 38.00M | 34.00M | 22.00M | 33.00M | 22.00M | 36.00M | 34.00M | 33.00M | 29.00M | 28.00M |
| Change in Working Capital | 226.00M | 154.00M | -202.00M | -144.00M | 5.00M | 38.00M | -41.00M | -226.00M | 119.00M | 55.00M | -58.00M | -195.00M |
| Operating Cash Flow | 290.00M | 1.05B | — | 94.00M | 250.00M | 913.00M | — | -119.00M | 419.00M | 1.05B | 650.00M | -67.00M |
| Capital Expenditures | -178.00M | -134.00M | -110.00M | -86.00M | -152.00M | -102.00M | -90.00M | -64.00M | -145.00M | -94.00M | -80.00M | -70.00M |
| Investing Cash Flow | -2.50B | -269.00M | -148.00M | -223.00M | -407.00M | -240.00M | -137.00M | -349.00M | -188.00M | -88.00M | -120.00M | -84.00M |
| Dividends Paid | -16.00M | -16.00M | -16.00M | -16.00M | -16.00M | -14.00M | -13.00M | -14.00M | -14.00M | -13.00M | -14.00M | -14.00M |
| Share Repurchases | -100.00M | 0 | -100.00M | -100.00M | 0 | 0 | 0 | — | — | — | — | — |
| Debt Repaid | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | 21.00M | -293.00M | -165.00M | 1.36B | -286.00M | -1.28B | 914.00M | -57.00M | -153.00M | -900.00M | -24.00M | -227.00M |
| Net Change in Cash | -2.23B | 486.00M | 264.00M | 1.29B | -416.00M | -679.00M | 1.55B | -547.00M | 59.00M | 86.00M | 475.00M | -389.00M |
| Free Cash Flow | 112.00M | 916.00M | — | 8.00M | 98.00M | 811.00M | — | -183.00M | 274.00M | 956.00M | 570.00M | -137.00M |
This table shows 12 quarterly periods of GE HealthCare Technologies's cash flow statement, from Q1 2026 back to Q2 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GEHC's reporting calendar. What is a cash flow statement?